4
Changes in Ownership
BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-21-025496
Director sold 5,000 shares at $15.06 ($75,300)
- Director acquired 5,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
ABERCROMBIE GEORGE B · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-09-15 | Exercise or conversion : show line 1 in the form | +5,000 | $2.63 | $13,150 | 5,000 | D |
| 2021-09-15 | Sale : show line 2 in the form | −5,000 | $15.06 | $75,300 | 0 | D |
| Open-market sales · 5,000 sh · avg $15.06 · $75,300 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-09-15 | Exercise or conversion : show line 3 in the form Non-Qualified Stock Option | −5,000 | 0 | D |
Loading xslF345X03/form4.xml…